Should I buy HCA Healthcare (HCA) stock or is it too late?
⭐ The most reliable of them, either direction: Morgan Stanley — 69% of its targets hit on this sector (825 calls tested). It aims for $380 (-9.4 %), call made on July 28, 2026, maturing on July 28, 2027 (31 d ago).
Firm-by-firm track record on HCA Healthcare
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| JP Morgan | 100 % | +33.1 % | 9 | $425 +1% |
| Mizuho | 89 % | +30.3 % | 19 | $475 +13% |
| Baird | 80 % | +29.8 % | 5 | $393 -6% |
| Truist Securities | 86 % | +28.1 % | 14 | $495 +18% |
| Jefferies | 75 % | +28.0 % | 8 | $590 +41% |
| UBS | 64 % | +23.3 % | 11 | $579 +38% |
| Stephens & Co. | 89 % | +22.7 % | 9 | $530 +26% |
| Argus Research | 80 % | +22.5 % | 5 | $560 +34% |
✅ Reasons to believe
- 63% of analysts rate it a buy (Buy consensus, 16 ratings) — a sign of market conviction.
- The most reliable firm on HCA, JP Morgan (100% hit rate, 9 scored calls), targets $425 (call made on August 20, 2026, maturing on August 20, 2027) (+1%) in its most recent call, and $535 (call made on February 20, 2026, maturing on February 20, 2027) (+28%) in the one coming due soonest.
- 5 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.
- Reasonable valuation (P/E ~14) relative to its sector.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 16 ratings, 5 are neutral and 1 is a sell.
- Limited upside: the median target is only +4% from the current price.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on HCA
Median target $435 (+4%) · 16 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in HCA Healthcare now?
We won't decide for you. The facts: 63% of analysts rate it a buy, median target $435 (+4%), and JP Morgan (most reliable on HCA, 100%) targets $425. Weigh that against valuation (P/E ~14). This is not personalized advice.
Is it too late to invest in HCA Healthcare?
Not according to analysts: the median target ($435) is still +4% above the current price ($419) (most reliable on HCA: JP Morgan, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is HCA Healthcare still worth investing in?
It depends on the gap between the price ($419) and its estimated value: analysts target $435 on median (+4%), with 63% buys (most reliable on HCA: JP Morgan, 100%). Cross-check with their real reliability on HCA and the cautions above. Information, not advice.
What's the main risk in buying HCA?
The consensus is not unanimous: of 16 ratings, 5 are neutral and 1 is a sell.
→ Go deeper: the full HCA Healthcare profile (consensus, analyst reliability, price target, performance).